Formycon AG

€14.10As of Sun 8 Nov 2026, 12:00 UTC
XETRA:FYBHealthcare
Country Germany
PE (Fwd) •••
TSR 10Y CAGR (2.89%)
Div yield —
ROE (6.33%)
Biotechnology
Beta (5Y) 0.67
PE TTM —
TSR TTM (35.62%)
Mkt cap €249.2M
ROIC (4.09%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
€16
12.35%
(59.95%)
Hold 2|6|8|11|4
4Q25
1Q26
2Q26
3Q26
Earnings per share€
0.29
0.32
0.36
0.37
20.63%
19.97%
31.78%
37.33%
Revenue€M
19.52
20.64
20.36
21.11
6.55%
9.57%
2.80%
5.57%
Peers (US$279.8M)
Cap (US$)
PE
192.3M
—
134.3M
—
Capital
TTM
5Y
10Y
Leveragex
0.646
(0.145)
(0.087)
EBIT/Intx
3.699
0.603
0.499
Own earn%
(135.71)
57.06
58.62
Sh yield%
27.53
13.99
13.91
Owners
Insiders/Inst%
3.55
50.93
Short interest%
3.01
SBC / revenue%
4.80
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
7
Op margin range%
9–16
$1 testx
0.0
Incr. ROIC%
4